RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Add to Collection
RCTs HJL Heerspink, BV Stefansson… - Nephrology Dialysis …, 2020 - academic.oup.com

Chapter : Section1, Section2
Journal Year : 2020
Cited by : 195

… Recruitment is monitored to ensure that a minimum of 30% of the patients were recruited to either the diabetic or non-diabetic subpopulation, there is adequate geographical …..... Read More

Keywords : ['chronic kidney disease dapackd randomize control trial', 'adverse outcome', 'rationale', 'protocol', 'prevention', 'dapagliflozin']
PubMed Link : https://academic.oup.com/ndt/article-abstract/35/2/274/5728707
Google Scholar Link : https://scholar.google.com/scholar?cites=16835607667203533966&as_sdt=4000005&sciodt=0,18&hl=en&num=20